J&J fleshes out US investment plan, telegraphing $1B cell therapy plant and 500 new jobs in PA

2026-03-07 03:53:21

Abstract generation in progress

Johnson & Johnson plans to invest over $1 billion in a new cell therapy production plant in Montgomery County, Pennsylvania, creating 500 permanent biomanufacturing jobs and 4,000 construction jobs. This investment is part of J&J’s broader $55 billion U.S. expansion strategy aimed at addressing potential pharmaceutical tariffs and boosting domestic production. The new facility will support the growing demand for cell therapies like Carvykti, which already exceeded blockbuster status last year and has previously faced supply constraints.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes